scholarly journals Decreasing Incidence of Symptomatic Epstein-Barr Virus Disease and Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplant Recipients: Report of the Studies of Pediatric Liver Transplantation Experience

2013 ◽  
Vol 19 (7) ◽  
pp. 730-740 ◽  
Author(s):  
Michael R. Narkewicz ◽  
Michael Green ◽  
Stephen Dunn ◽  
Michael Millis ◽  
Susan McDiarmid ◽  
...  
Keyword(s):  
Lymphoproliferative Disorder ◽  
Epstein Barr Virus ◽  
Virus Disease ◽  
Transplant Recipients ◽  
Posttransplant Lymphoproliferative Disorder ◽  
Barr Virus ◽  
Pediatric Liver ◽  
Epstein Barr ◽  
Liver Transplant Recipients ◽  
Pediatric Liver Transplant

scholarly journals Immunologic and Virologic Analyses in Pediatric Liver Transplant Recipients with Chronic High Epstein‐Barr Virus Loads

2010 ◽  
Vol 202 (3) ◽  
pp. 461-469 ◽  
Author(s):  
Kensei Gotoh ◽  
Yoshinori Ito ◽  
Rieko Ohta ◽  
Seiko Iwata ◽  
Yukihiro Nishiyama ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Epstein Barr Virus ◽  
Transplant Recipients ◽  
Barr Virus ◽  
Pediatric Liver ◽  
Epstein Barr ◽  
Liver Transplant Recipients ◽  
Pediatric Liver Transplant

Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients

2000 ◽  
Vol 32 (1) ◽  
pp. 100-104 ◽  
Author(s):  
Françoise Smets ◽  
Monique Bodeus ◽  
Patrick Goubau ◽  
Raymond Reding ◽  
Jean-Bernard Otte ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Primary Infection ◽  
Epstein Barr Virus ◽  
Transplant Recipients ◽  
Barr Virus ◽  
Pediatric Liver ◽  
Epstein Barr ◽  
Liver Transplant Recipients ◽  
Pediatric Liver Transplant

Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients

2019 ◽  
Vol 29 (2) ◽  
pp. 185-193 ◽  
Author(s):  
Michelle Liu ◽  
Shahid Husain ◽  
Olusegun Famure ◽  
Yanhong Li ◽  
S. Joseph Kim
Keyword(s):  
Risk Factors ◽  
Lymphoproliferative Disorder ◽  
Epstein Barr Virus ◽  
Transplant Recipients ◽  
Posttransplant Lymphoproliferative Disorder ◽  
Kidney Transplant Recipients ◽  
Barr Virus ◽  
Incidence Risk ◽  
Epstein Barr

Background: Posttransplant lymphoproliferative disorder (PTLD) is a severe complication after kidney transplantation. This study examined the incidence, risk factors, clinical management, and outcomes of PTLD in a cohort of kidney transplant recipients. Design: This single-center cohort study included 1642 patients transplanted from January 1, 2000, to December 31, 2012, with follow-up until December 31, 2013. The incidence and risk factors for PTLD were examined using a Cox proportional hazards model. A Cox model was also used to assess the association of PTLD and graft outcomes. Results: Sixteen recipients developed PTLD over follow-up. The incidence rate was 0.18 (95% confidence interval [CI]: 0.11-0.29) cases per 100 person-years. Four were from Epstein–Barr virus (EBV) mismatched (D+/R−) transplants and 12 from EBV-positive recipients (R+). Recipients with D+/R− matches were at a significantly higher risk of developing PTLD than R+ (hazard ratio [HR]: 7.52 [95% CI: 2.42-23.32]). Fifteen cases had immunosuppression reduced, 11 cases were supplemented with rituximab or ganciclovir, 6 cases required chemotherapy or radiation, and 6 cases had tumors excised. By the end of follow-up, 6 patients went into remission, 5 returned to chronic dialysis, and 5 patients died. Patients with PTLD were significantly more likely to have total graft failure (return to chronic dialysis, preemptive retransplant, or death with graft function) than patients without PTLD (HR: 3.41 [95% CI: 1.72-6.78). Discussion: Epstein–Barr virus mismatch continues to be a strong risk factor for developing PTLD after kidney transplantation. Recipients with PTLD have a poor prognosis, as the optimal management remains to be elucidated.

Sign in / Sign up

Export Citation Format

Share Document